Article Information
History
- January 19, 2018.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Jason M. Rohdea,*,
- Kyle R. Brimacombea,
- Li Liua,h,
- Michael E. Pacolda,
- Adam Yasgara,
- Dorian M. Cheffa,
- Tobie D. Leea,
- Ganesha Raia,
- Bolormaa Baljinnyama,
- Zhuyin Lia,i,
- Anton Simeonova,
- Matthew D. Halla,
- Min Shena,
- David M. Sabatinib,e and
- Matthew B. Boxera,j
- aNational Center for Advancing Translational Sciences, National Institutes of Health, 9800 Medical Center Drive, Rockville, MD, 20850, USA
- bWhitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, MA, 02142, USA
- cHoward Hughes Medical Institute, Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA
- dKoch Institute for Integrative Cancer Research, 77 Massachusetts Avenue, Cambridge, MA 02139, USA
- eBroad Institute of Harvard and Massachusetts Institute of Technology, 7 Cambridge Center, Cambridge, MA 02142, USA
- fDana-Farber Cancer Institute, Longwood Center, 350 Longwood Avenue, Boston, MA 02215, USA
- gDepartment of Radiation Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA
- hDepartment of Radiation Oncology, New York University Medical Center, 522 First Avenue, Smilow 907, New York, NY 10016
- iBristol-Myers Squibb, Lead Discovery and Optimization, 3551 Lawrenceville Road, Princeton, NJ 08540
- jNexus Discovery Advisors, 7820B Wormans Mill Road, Suite 208, Frederick, MD 21701
- ↵*To whom correspondence should be addressed: Jason Rohde, Ph.D., 9800 Medical Center Dr., Rockville, MD 20850, Phone: 301-827-1755. Fax: 301-217-5736. Email: jason.rohde{at}nih.gov
Posted January 19, 2018.
Discovery and optimization of piperazine-1-thiourea-based human phosphoglycerate dehydrogenase inhibitors
